Lauritz R Meyer1, Benjamin Dexter2, Cecilia Lo2, Elizabeth Kenkel2, Takahito Hirai3, Robert D Roghair4, Sarah E Haskell4. 1. a Department of Pediatrics , Sanford Health , Sioux Falls , SD , USA. 2. b Stead Family Department of Pediatrics , University of Iowa Carver College of Medicine , Iowa City , IA , USA. 3. c Kindai University Faculty of Medicine , Higashiosaka, Osaka , Japan. 4. d Stead Family Department of Pediatrics , University of Iowa Carver College of Medicine , Iowa City , IA , USA.
Abstract
PURPOSE: Associations have been made between maternal selective serotonin reuptake inhibitor (SSRI) use during pregnancy and altered behavior in offspring, including an increased risk of autism. Given the important role serotonin plays in behavior, we hypothesized SSRI exposure in the perinatal period would alter central serotonin receptor expression and program adult behaviors in mice. METHODS: Female mice were injected with sertraline or saline throughout pregnancy. Offspring continued to receive injections on postnatal days 1-14, a time period in mice similar to the third trimester in human pregnancy. Adult offspring underwent behavioral testing, and serotonin receptor mRNA levels were quantified. RESULTS: Compared to controls, SSRI exposed mice did not have a reduction in social interactions, spatial learning, or exploratory behavior. As adults, sertraline exposed mice had significantly increased mRNA levels of multiple 5-HT receptors, serotonin transporter (5-HTT), and tryptophan hydroxylase isoform 2 in the cerebral cortex. CONCLUSION: Although no behavioral phenotype was observed, SSRI exposure in the perinatal period permanently alters cerebral receptor mRNA levels. We speculate these shifts in mRNA expression provide important compensation during SSRI exposure. Further pre-clinical and clinical investigation into additional serotonin-regulated phenotypes is necessary to further assess the long-term implications of perinatal SSRI exposure.
PURPOSE: Associations have been made between maternal selective serotonin reuptake inhibitor (SSRI) use during pregnancy and altered behavior in offspring, including an increased risk of autism. Given the important role serotonin plays in behavior, we hypothesized SSRI exposure in the perinatal period would alter central serotonin receptor expression and program adult behaviors in mice. METHODS: Female mice were injected with sertraline or saline throughout pregnancy. Offspring continued to receive injections on postnatal days 1-14, a time period in mice similar to the third trimester in human pregnancy. Adult offspring underwent behavioral testing, and serotonin receptor mRNA levels were quantified. RESULTS: Compared to controls, SSRI exposed mice did not have a reduction in social interactions, spatial learning, or exploratory behavior. As adults, sertraline exposed mice had significantly increased mRNA levels of multiple 5-HT receptors, serotonin transporter (5-HTT), and tryptophan hydroxylase isoform 2 in the cerebral cortex. CONCLUSION: Although no behavioral phenotype was observed, SSRI exposure in the perinatal period permanently alters cerebral receptor mRNA levels. We speculate these shifts in mRNA expression provide important compensation during SSRI exposure. Further pre-clinical and clinical investigation into additional serotonin-regulated phenotypes is necessary to further assess the long-term implications of perinatal SSRI exposure.
Authors: Christina L Wichman; Amy Fothergill; Katherine M Moore; Tara R Lang; Robert H Heise; William J Watson Journal: J Clin Psychopharmacol Date: 2008-12 Impact factor: 3.153
Authors: Marian K Bakker; Pieternel Kölling; Paul B van den Berg; Hermien E K de Walle; Lolkje T W de Jong van den Berg Journal: Br J Clin Pharmacol Date: 2007-10-22 Impact factor: 4.335
Authors: Rebecca A Harrington; Li-Ching Lee; Rosa M Crum; Andrew W Zimmerman; Irva Hertz-Picciotto Journal: Pediatrics Date: 2014-04-14 Impact factor: 7.124
Authors: Sabrina I Hanswijk; Marcia Spoelder; Ling Shan; Michel M M Verheij; Otto G Muilwijk; Weizhuo Li; Chunqing Liu; Sharon M Kolk; Judith R Homberg Journal: Int J Mol Sci Date: 2020-08-14 Impact factor: 5.923